Transactions

  • April 2018

    Advisory of
    Advent Internationals
    in the €1.9bn acquisition of Zentiva

  • December 2017

    Sale of
    Selcia
    global CRO for radiolabeling services to Eurofins

  • May 2016

    Sale of
    EMP
    Levothyroxine oral solution European rights to Helm

  • April 2018

    Advisory of
    Alvogen
    in the acquisition of US specialty generics company COUNTY LINE PHARMACEUTICALS

  • March 2016

    Advisory of
    CVC Capital Partners
    in the acquisition of Italian generics company DOC Generici Per Scelta

  • June 2015

    Advisory of
    CVC Capital Partners
    in the acquisition of a controlling equity stake in Alvogen

  • March 2015

    Advisory of
    Patheon
    in the acquisition of specialty API manufacturer Irix

  • November 2013

    Advisory of
    Patheon
    in the $2.6bn merger with DSM

  • June 2012

    Advisory of
    Hermes Arzneimittel
    in partnering OTC Vitamin + Calcium Franchise to Warner Chilcott

  • October 2010

    Advisory of
    Siegfried
    in the sale of PulmoJet DPI Franchise to Sanofi

  • April 2009

    Licensing of
    UCL
    Phase 1 Hepatology Product by Ocera

  • April 2007

    Licensing of
    Bayer
    Phase 1 Oncology Product by Syndax

  • September 2009

    Licensing of
    Aetas
    Phase 1 Acute Cardiovascular Product by Nova Cardia

  • August 2004

    Sale of
    ASAT AG
    Phase 2 Dermatology Product to Biofrontera